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Abstract
Background
Acute kidney injury (AKI) is assoicated with high mortality and measures to improve risk
stratification and early identification have been urgently called for. This study investigated
whether an electronic clinical prediction rule (CPR) combined with an AKI e-alert could
reduce hospital-acquired AKI (HA-AKI) and improve associated outcomes.
Methods and findings
A controlled before-and-after study included 30,295 acute medical admissions to two adult
non-specialist hospital sites in the South of England (two ten-month time periods, 2014–16);
all included patients stayed at least one night and had at least two serum creatinine tests. In
the second period at the intervention site a CPR flagged those at risk of AKI and an alert
was generated for those with AKI; both alerts incorporated care bundles. Patients were fol-
lowed-up until death or hospital discharge. Primary outcome was change in incident HA-
AKI. Secondary outcomes in those developing HA-AKI included: in-hospital mortality, AKI
progression and escalation of care. On difference-in-differences analysis incidence of HA-
AKI reduced (odds ratio [OR] 0.990, 95% CI 0.981–1.000, P = 0.049). In-hospital mortality in
HA-AKI cases reduced on difference-in-differences analysis (OR 0.924, 95% CI 0.858–
0.996, P = 0.038) and unadjusted analysis (27.46% pre vs 21.67% post, OR 0.731, 95% CI
0.560–0.954, P = 0.021). Mortality in those flagged by the CPR significantly reduced (14%
pre vs 11% post intervention, P = 0.008). Outcomes for community-acquired AKI (CA-AKI)
cases did not change. A number of process measures significantly improved at the interven-
tion site. Limitations include lack of randomization, and generalizability will require future
investigation.
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Conclusions
In acute medical admissions a multi-modal intervention, including an electronically inte-
grated CPR alongside an e-alert for those developing HA-AKI improved in-hospital out-
comes. CA-AKI outcomes were not affected. The study provides a template for
investigations utilising electronically generated prediction modelling. Further studies should
assess generalisability and cost effectiveness.
Trial registration
Clinicaltrials.org NCT03047382.
Introduction
Acute kidney injury (AKI) is a clinical syndrome, defined through an acute increase in serum
creatinine (SCr) and/or reduction in urine volume. However, there is a continuum of injury
before sufficient loss of excretory kidney function can be detected with a change in SCr [1]. Up
to 20% of adults admitted acutely to hospital meet AKI KDIGO (Kidney Disease: Improving
Global Outcomes) criteria at, or during their stay, with high associated mortality [2]. This may
reflect the limited ability of conventional markers to detect renal injury in a timely fashion, as
well as heterogeneity in aetiology, which in turn provides some explanation as to why clinical
trials of therapeutic interventions have proved disappointing [3].
There has been an international call to address deficits in recognition and management of
patients with AKI, including early risk assessment at which point interventions could be most
beneficial [1, 4, 5]. Implementation of clinical prediction rules (CPRs) is one strategy to
improve risk assessment [6, 7], which relate multiple predictors, such as medical history and
diagnostic tests, to risk of an outcome [8]. Unfortunately few CPRs have undergone impact
analyses to investigate whether implementation is beneficial, with no such studies in the field
of hospital-acquired AKI (HA-AKI). A second strategy, investigated predominantly by before-
after observational studies, is the use of AKI e-alerts, with process measure improvements,
such as reduced use of nephrotoxic medications, inconsistently reported [7]. Two studies from
the UK reported reduced in-patient mortality and AKI progression in patients who had a
linked care bundle completed [9, 10], and a large US before-after study suggested a significant
reduction in mortality with the introduction of an AKI alert [11]. However, the only random-
ized controlled trial (RCT) reported to date utilising an e-alert showed no benefit [12]. An
NHS patient safety alert in 2014 mandated English hospitals deploy an e-alert upon AKI devel-
opment [13], however, uncertainty around the relative benefits of alerts and CPRs remains,
necessitating ongoing rigorous evaluation [7, 14].
This impact analysis study employed one of the few available externally validated AKI
CPRs–the Acute Kidney Injury Prediction Score (APS)—derived in a UK general medical pop-
ulation, which combines data on age, medical history and physiological parameters [15, 16].
The aims of the study included:
i. In emergency medical admissions, without identifiable AKI at admission, could introduc-
tion of an electronically generated AKI CPR reduce the incidence of HA-AKI,
ii. In concert with the CPR, does an e-alert for new HA-AKI reduce associated complications
including in-hospital mortality, escalation to intensive care and maximal AKI stage,
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iii. Does identification of a group at high risk of developing HA-AKI improve outcomes,
iv. What is the effect of e-alerting community-acquired AKI (CA-AKI) at admission to
hospital?
Methods
Ethical approval was given by NHS Research Ethics Committee London—City Road and
Hampstead (REC reference 13/LO/0960) and the study registered with clinicaltrials.org
(NCT03047382) (S1 Protocol and S1 TREND Checklist available as supplementary files)
[17]. A prospective controlled before-after impact analysis of the APS CPR and AKI e-alert
was performed on two adult general acute medical units. Part of the same NHS Trust, the
two sites were split into intervention and control and the study ran over two ten-month
periods (2014–2016). There was a bed down period for the intervention of two months
whilst the technology was safely introduced (Table A in S1 File for variables and weightings
of the APS CPR). The Trust is a non-specialist hospital organisation of 870 beds, with the
two sites 20 miles apart with similar catchment areas on the South Coast of England, though
the control site has a higher rural population and less socio-economic deprivation [18].
Combined annual emergency department attendance is over 135,000 with 40–60 acute
medical admissions per 24-hour period. The APS CPR was derived at the intervention site
[15]. There was no cross-site contamination of clinical staff during the study: Consultant
physicians and nursing staff do not work on both sites, nor do junior staff rotate between
the hospitals (see Table 1 for demographic and clinical characteristics of the emergency
admissions).
At admission, all in-patients have physiological observations measured and entered via
handheld systems into the clinical data software system (Patientrack Sydney, NSW, Australia).
Previous ICD-10 coded history (heart failure, liver disease and diabetes mellitus), were
retrieved and chronic kidney disease (CKD) was defined as an eGFR<60 mls/min/1.73m2
prior to admission (in those with an available baseline SCr); baseline SCr was defined using
NHS England’s National algorithm [19]. KDIGO criteria for AKI was employed using only
SCr as few of this patient group have routine urinary catheters placed (SCr increase of1.5
Table 1. Demographics and clinical characteristics of all patients pre and post intervention.
Intervention Site Control Site
Pre (n = 7,532) Post (n = 8,636) P value Pre (n = 6,749) Post (n = 7,378) P value
Age, mean (SD) 75.1 (±16.9) 74.2 (±17.4) 0.001 74.6 (±16.7) 74.1 (±16.9) 0.149
NEWS, median (IQR) 1 (0–3) 1 (0–3) 0.009 2 (0–3)# 1 (0–3) 0.013
Respiratory rate20 27.2% # 25.8%# 0.054 20.2% 18.3% 0.003
<Alert on AVPU scale 1.3% 1.3% 0.944 1.2% 1.0% 0.339
CKD 47.7% 46.5% 0.122 49.1% 45.9% <0.001
Diabetes 22.3% 23.7% 0.045 22.6% 23.2% 0.367
Heart failure 24.2% 24.4% 0.797 23.1% 23.4% 0.705
Liver disease 2.7%# 3.1%# 0.110 1.9% 2.0% 0.903
Hypertension 62.1%# 59.6%# 0.001 56.9% 55.1% 0.034
Vascular disease 10.3% # 10.3%# 0.959 6.5% 7.6% 0.014
IQR–Interquartile range, SD–standard deviation. AVPU–best response: Alert, Vocal, Pain, Unresponsive, CKD–chronic kidney disease (baseline estimated glomerular
filtration rate <60mls/min), NEWS–National early warning score, Respiratory rate–breaths/minute.
# = significant difference (P<0.05) between sites during same period. T-test, Mann Whitney U tests or χ2.
https://doi.org/10.1371/journal.pone.0200584.t001
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from baseline value or absolute value354μmol/l for CA-AKI; increase1.5 from admission
value or26.5μmol/l within a rolling 48 hours during the first seven days of admission for
HA-AKI). If no baseline was available, CA-AKI was assumed absent unless SCr was
354μmol/l. Patients were included if18 years of age, stayed at least one night in the medical
unit and had at least one SCr repeated.
Exclusion criteria:
• Patients moved directly from the A&E department to the ICU (as neither area uses the
Patientrack data system),
• Aged<18 years,
• Non-medical (General Surgery, Trauma & Orthopaedics, Obstetrics and Gynaecology)
admissions and,
• Discharged without spending a night in hospital.
Patients were followed-up until hospital discharge or in-hospital death (Fig 1 summarises
the flow of participants in the study periods). As all patients admitted had an APS calculated
Fig 1. Consort diagram inclusion and exclusions. CA-AKI–Community-acquired AKI, HA-AKI–Hospital-acquired AKI, SCr–serum Creatinine.
https://doi.org/10.1371/journal.pone.0200584.g001
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automatically by the Patientrack system before any outcome had occurred, there were no miss-
ing demographic or physiological data at admission.
Intervention
The intervention is summarised in Fig 2. At admission those with an APS5 points were
flagged ‘at risk of AKI’ (coloured AMBER) in multiple electronic locations (Fig 3) and a care
bundle generated (Tables B and C In S1 File). Those with an APS <5 points were classed
GREEN, with no alert. This cut-off was chosen for its relatively high specificity and positive
predictive value in derivation and validation, aiming to minimise false-positives that may limit
uptake [15, 16]. Patients with CA-AKI were flagged RED, as were all who subsequently devel-
oped HA-AKI, with care bundles generated. Response was multidisciplinary: ward physicians,
nurses, health care assistants and pharmacists, together with the critical care outreach nurse
team reviewing patients remotely or at the bedside. None of the researchers involved in data
analysis were involved in management of the patients and had access only to the fully anon-
ymised individual level data and were blinded to other patient data, as well as components of
the calculated APS score.
Barriers to integration and acceptance of CPRs and clinical decision support systems
(CDSS) and expert guidance were considered prior to incorporation into the clinical workflow
as part of a multi-faceted AKI guideline implementation [20, 21]. The controlled before-after
design has been reported in previous impact analysis studies [22, 23]. The mandated NHS
England patient safety alert limited the timeframe over which the study, a natural experiment,
could be performed before the e-alert was introduced at the second (control) site.
Fig 2. Summary of intervention. At the control site no alerts were generated. RED boxes = AKI (community or hospital-acquired), AMBER = APS5
points–cut-off for flagging patient at risk of AKI, GREEN box–all other patients (APS<5 points). HA-AKI–Hospital-acquired AKI, PAS–Patient
administration system, SCr–serum creatinine. Patientrack AKI ALERT ^AKI Prediction Score (APS)–clinical prediction rule.
https://doi.org/10.1371/journal.pone.0200584.g002
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Outcomes
The primary outcome to assess the APS CPR was change in incidence of HA-AKI (KDIGO
change in SCr) within seven days of hospital admission following intervention when adjusting
for baseline differences between intervention and control sites. Other outcomes in those who
developed HA-AKI included mortality in-hospital and seven days following admission, maxi-
mal increase in AKI KDIGO Stage and in SCr from admission, and ICU escalation. These out-
comes were also assessed in patients highlighted by the CPR at high AKI risk (AMBER) and
for patients with CA-AKI. Process measures were collected to attempt to explain the effects of
the intervention. These included drug prescribing, completion of the suggested care bundles
and a notes review of a randomly selected collection of HA-AKI cases.
Fig 3. Top left (A): Patient tile indicating presence and stage of AKI, baseline SCr and care bundle task status; top right (B): electronic observation chart with AKI status
(present or at risk) in top right of screen with link to SCr results; bottom left (C): graph of SCr; bottom right (D): AKI care bundle. SCr–serum creatinine. Note that details
for illustration only and are not of a real patient.
https://doi.org/10.1371/journal.pone.0200584.g003
Impact analysis of a clinical prediction rule and electronic AKI alert
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Statistical analysis
To avoid potential bias due to existing background differences between hospitals and temporal
changes, we adopted the difference-in-differences approach by including time variable
(before-after) and its interaction with the hospitals [24–29]. All models were adjusted by age
and co-morbidities (ICD-10 diagnoses of heart failure, CKD, vascular disease, hypertension,
diabetes mellitus and liver disease). The estimates of the intervention with a time period inter-
action term with associated 95% confidence intervals were reported. Difference-in-differences
analysis makes two main assumptions [26]. First, the parallel trends assumption holds that
intervention and control groups have equivalent trends for the outcome(s) prior to the start of
the intervention. This implies that, without treatment, outcome(s) would be expected to
change at the same rate. Secondly, the common shocks assumption infers that any event(s)
occurring during or after the intervention will equally affect the intervention and control
groups. To test whether the groups’ case mix did not change differentially over time, we exam-
ined for differences between patient characteristics before and after implementation in both
groups (Table 1). Generalised estimating equations (GEE) with logistic link function were cho-
sen to estimate the risks of binary outcomes between the intervention and control hospitals.
GEE takes into account the clustering effects of multiple hospital admissions for the same indi-
viduals [30]. Generalised linear mixed models were employed to analyses continuous variables
(change in SCr and hospital length of stay) including individual patients as a random effect
[27]. Categorical outcomes were evaluated with the Cochran-Mantel-Haenszel χ2 tests. T-tests
or Mann-Whitney U tests were used to compare continuous variables. Data were extracted
fully anonymised on Microsoft1 Excel1 and all analyses were conducted using SAS (V9.41).
Results
Over the 20-month study period 30,295 admissions were analysed (Fig 1) with a mean age of
74.5 (standard deviation ±17.0), length of stay 11 days (±13.1) and in-hospital mortality 8.3%.
AKI was present on admission (CA-AKI) in 8.3% (n = 2,502) and 7.3% (n = 2,040) developed
HA-AKI. Table 1 shows the sites were relatively well matched at admission pre and post inter-
vention, though the intervention site had higher lengths of stay, age, admission tachypnoea
and some coded co-morbidities (liver disease, hypertension and vascular disease). Across all
medical admissions between periods, at both sites there was no overall change in mortality,
whilst length of stay reduced (Table D in S1 File). More patients were escalated to ICU at the
intervention site in the second period (P = 0.013) though on difference-in-differences analysis
there was no significant change in mortality or escalation to ICU.
Incidence of HA-AKI
Difference-in-differences analysis suggested a reduction in HA-AKI at the intervention site
(OR 0.990, 95% CI 0.981–1.000, P = 0.049). Unadjusted incidence of HA-AKI did not change
Table 2. Incident HA-AKI pre and post intervention unadjusted and difference-in-differences analysis.
Intervention site Control site Adjusted difference-in-differences change in
outcome for intervention site vs control site
Outcome Before
(n = 6,862)
After
(n = 7,881)
OR (95% CI), P
value
Before
(n = 6,258)
After
(n = 6,792)
OR (95% CI), P
value
OR (95% CI), P value
HA-AKI 8.28%
(n = 568)
7.73%
(n = 609)
0.928 (0.824–
1.045), 0.223
6.55%
(n = 410)
6.67%
(n = 453)
1.019 (0.888–
1.170), 0.805
0.990 (0.981–1.000), 0.049
HA-AKI–hospital-acquired AKI, OR–odds ratio.
https://doi.org/10.1371/journal.pone.0200584.t002
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significantly at the intervention (8.28% pre, 7.73% post intervention, OR 0.928, 95% CI 0.824–
1.045, P = 0.223) or control sites (6.55% pre, 6.67% post intervention, OR 1.019, 95% CI
0.888–1.170, P = 0.805) (Table 2). In patients with only a single admission during the period of
study, HA-AKI significantly reduced at the intervention site (9.4% pre vs 7.1% post interven-
tion, OR 0.739, 95% CI 0.618–0.884, P = 0.001), with no change at the control site (6.7% pre,
6.2% post intervention, OR 0.910, 95% CI 0.735–1.127, P = 0.412).
HA-AKI outcomes
In cases of new HA-AKI in-patient mortality, using difference-in-differences analysis, signifi-
cantly reduced at the intervention site (OR 0.924, 95% CI 0.858–0.996, P = 0.038) (Fig 4).
Unadjusted in-patient mortality decreased at the intervention site (27.46% pre vs 21.67% post,
OR 0.731, 95% CI 0.560–0.954, P = 0.021) with no change at control site (22.92% pre vs
24.72% post, OR 1.104, 95% CI 0.807–1.511, P = 0.576) (Table 3). A similar reduction in mor-
tality by day seven was found. ICU escalation, progression to stage 3 AKI and maximal
increase in SCr reduced at the intervention site, whilst increasing at the control site, without
reaching statistical significance on difference-in-differences analysis. Length of stay did not
change at either site.
Fig 4. In-patient mortality in cases who developed HA-AKI before and after the intervention. HA-AKI–hospital-acquired AKI, OR–odds ratio (95% CI).
https://doi.org/10.1371/journal.pone.0200584.g004
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At the intervention site, of those flagged as high risk (AMBER alert) 14% went on to develop
HA-AKI vs 5% with no flag (GREEN), P<0.001. Following the intervention, in-patient mortal-
ity in this high-risk amber group significantly decreased (14% pre vs 11% post, OR 0.78, 0.66–
0.94, P = 0.008) with no change at control site (Table 4 and Table E in S1 File). There were no
significant changes in outcomes in those with CA-AKI at either site including mortality and
AKI progression (Table 4 and Table E in S1 File). Process measure improvements at the inter-
vention site vs control included an increased stopping of potentially nephrotoxic medications
(P<0.001) and AKI documentation (P = 0.033) (Tables F and G in S1 File). Electronic bundle
compliance (submission of a complete bundle) was 26% in those with AKI and 15% in all
those flagged at risk.
Discussion
This is the first impact analysis study combining an AKI CPR and an AKI e-alert in hospital-
ised patients. The intervention was associated with a decrease in the incidence of new AKI but,
importantly a significant improval in survival in those individuals who developed HA-AKI
was also found. This may reflect a synergistic benefit of highlighting those at risk and de novo
AKI, implying best practice would be institution of a care bundle in both groups, in tandem
with a multimodal service improvement approach. Other outcome measures including
Table 3. HA-AKI cases—pre and post intervention outcomes with adjusted difference-in-differences.
Intervention Site Control Site Adjusted difference-in-differences
change in
outcome for intervention site
vs control site
Outcome Before
(n = 568)
After
(n = 609)
OR (95% CI), P
value
Before
(n = 410)
After
(n = 453)
OR (95% CI), P
value
OR (95% CI), P value
In-patient
mortality
27.46%
(n = 156)
21.67%
(n = 132)
0.731 (0.560–0.954),
0.021
22.92%
(n = 94)
24.72%
(n = 112)
1.104 (0.807–1.511),
0.576
0.924 (0.858–0.996), 0.038
7-day
mortality
16.20%
(n = 92)
10.51%
(n = 64)
0.608 (0.432–0.855),
0.004
9.02% (n = 37) 12.58%
(n = 57)
1.451 (0.937–2.247),
0.101
0.907 (0.859–0.957), <0.001
Stage 3 AKI 8.27% (n = 47) 6.57% (n = 40) 0.779 (0.503–1.208),
0.268
4.15% (n = 17) 5.52% (n = 25) 1.350 (0.718–2.538),
0.429
P = 0.592
ICU
escalation
7.39% (n = 42) 6.90% (n = 42) 0.928 (0.595–1.446),
0.821
7.07% (n = 29) 10.6% (n = 48) 1.557 (0.962–2.521),
0.074
0.980 (0.942–1.020), 0.319
Peak SCr rise 71.0 (±77.4) 66.1 (±76.3) P = 0.269 64.6 (±61.0) 64.3 (±59.0) P = 0.939 0.968 (0.931–1.007), 0.107
Length of
Stay
14.7 (±15.4) 15.0 (±13.9) P = 0.708 15.4 (±14.3) 13.7 (±12.9) P = 0.064 P = 0.194
Mean (Standard deviation), HA-AKI–hospital-acquired AKI, ICU–intensive care unit, OR–odds ratio, SCr–serum creatinine, Stage 3 –KDIGO Staging x3 increase SCr.
https://doi.org/10.1371/journal.pone.0200584.t003
Table 4. In-patient mortality in cases with CA-AKI and in those flagged at high-risk on admission by the CPR.
Intervention Site Control Site
Before After OR (95% CI), P-value Before After OR (95% CI), P-value
CA-AKI Cases n = 670 n = 755 n = 491 n = 586 OR (95% CI), P-value
In-patient mortality 23% 23% 101 (079–129), 095 19% 17% 086 (063–117), 0.34
AMBER (APS5) n = 2,057 n = 2,351 n = 1,810 n = 1,851
In-patient Mortality 14% 11% 078 (066–094), 0008 10% 10% 096 (078–120), 074
CA-AKI–community-acquired AKI, OR–odds ratio. AMBER—APS5 points.
https://doi.org/10.1371/journal.pone.0200584.t004
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escalation of care and progression of AKI were suggested. There was no change in outcome
following introduction of an e-alert for patients with established AKI at admission to hospital,
indicating the measures introduced did not affect the underlying disease process.
The primary aim of the study was to investigate whether an AKI CPR could prevent
HA-AKI. On a difference-in-differences analysis a reduction was achieved. The treatment
effect may have been limited due to a lack of specificity in the CPR—in derivation and valida-
tion the APS had moderate discrimination (AUROC of 0.65–0.72) and to avoid alert fatigue,
only patients with a score5 were alerted to [15, 16]. Furthermore, as AKI was only diagnosed
through change in SCr, known to lag behind insult [31], it is possible a proportion classed as
HA-AKI reflected community-acquired injury. Further important findings are that both in
those highlighted as at high risk of developing AKI (AMBER) and in patients who subse-
quently developed HA-AKI, improved mortality outcomes were found, which may reflect sys-
tematic early recognition, with prompt care initiated even without documented evidence of a
completed care bundle. Indeed without these alerts many of these patients would not have trig-
gered an urgent response: for example median national early warning score (NEWS) was only
2 in the AMBER group, yet mortality ranged 11–14%. Based on the NEWS alone, such patients
would not have been flagged high risk. This study provides evidence that application of best
practice can translate into improved outcomes even in a heterogenous group at high risk of
complications.
Comparison with other studies
To date, the only RCT of an AKI e-alert showed no outcome benefit, though the intervention
in that study was limited to an electronic link to practice guidelines [12]. In two UK studies, in
patients who had developed AKI, a mortality benefit was reported in the 22–26% of those with
a completed care bundle [9, 10]. A recent large before-after study in the US suggested a signifi-
cant mortality benefit for the use of an AKI flag [11]. A before-after study where an alert was
delivered the day after AKI recognition, found improved appropriate renal function monitor-
ing, increased nephrology consultations and found less severe AKI after the intervention.
However the groups had significant differences and there was no contemporaneous control.
[32] One cluster RCT of a CDSS targeting patients with impaired renal found a significant
increase in appropriate adjusting of prescribing which supports our finding of improved pre-
scribing.[33] Though rarely reported, other CPR impact analysis studies have described suc-
cessful integration into a CDSS [34, 35].
Intervention uptake
The majority of studies reporting on the effects of alerts incorporated as part of CDSSs are
medication related [36], however, such recommendations are often ignored [37–39]. Relatively
little evidence explains why some succeed, with a paucity of evidence to demonstrate convinc-
ing improvement in patient outcomes [21, 40–42]. However, two systematic reviews [21, 43],
suggested three independent factors influence success:
• automatic provision of decision support as part of clinician workflow at the time and loca-
tion of decision-making,
• provision of recommendations rather than just assessments and,
• computer based decision support.
These factors and others were considered during study design, which provides a proof of
concept for future investigations of complex healthcare interventions. Alerts could be quickly
Impact analysis of a clinical prediction rule and electronic AKI alert
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acknowledged, with a single alert at admission for those at risk, with a further alert on patients
who met AKI criteria within the nursing clinical workflow [21, 44]. A cut-off on the APS CPR
was chosen to minimise false positives to avoid blunting and eventual elimination of responses
[45, 46]. Optimal visual field positioning and the use of appropriate colours (red and amber)
were chosen as they are associated with an increase in hazard perception and prioritisation
[47–50]. Despite these measures, compliance with electronic submission of care bundles was
low ranging 15–26%, similar to previous AKI studies [9, 51, 52]. This could have been
improved by making the alert interruptive however, this may have increased frustration and
alert fatigue [9, 53, 54]. Physicians were expected to submit the completed bundle however it
was not part of their workflow. However, crucially the intervention was multimodal: highly
visible flagging in multiple electronic areas accessed by all members of the clinical team, along-
side education, that may have changed group behavior not captured by a formal bundle sub-
mission. Whilst establishing conclusive proof of behavioural change is challenging, we found
significant improvement in process measures, such as stopping potential nephrotoxic
medication.
Study strengths and weaknesses
This natural experiment introducing an electronic alert intervention at one site within a simi-
lar geographical area to a control site allows for unrelated change in disease occurrence and
practice, with adjustment for confounders and has been described in previous impact studies
[22, 23]. HA-AKI associated mortality at the two sites (20–26%) was similar to the other UK
study showing a mortality benefit [9]. The process measure evaluation identified increased
documentation, coding of AKI and stopping of nephrotoxic medications at the intervention
site, which adds to the main data analysis suggesting both improved recognition and clinician
behaviours following intervention (Tables F and G in S1 File).
The study took place as part of an information technology service improvement interven-
tion that did not allow for a RCT design, with selection bias a concern. Between sites in both
periods overall mortality was higher at the intervention site, as was the rate of HA-AKI, which
may reflect differences in co-morbidities and socioeconomic factors. However, the before-
after controlled design using difference-in-difference analyses is accepted as a way of detecting
the effects of an intervention, and to control for confounders and secular trends [55, 56]. Out-
comes did not improve in the control hospital suggesting other external factors did not signifi-
cantly influence outcomes seen at the intervention site. However, given the difficulty of
eliminating bias, a single study is unlikely to be definitive and replication and synthesis of evi-
dence across studies is needed to support inferences about effectiveness [57]. Future studies of
such organizational interventions could include a cluster RCT design to address for potential
limitations of the presented study. A lack of power from two sites over ten-month periods
could explain why outcomes, including ICU escalation and AKI severity, though improving at
the intervention site, did not reach statistical significance–though for example in the second
period significantly fewer patients with HA-AKI were escalated than at the control site. Gener-
alisability may be limited by the study population on the South-Coast of England, being older
(mean age 74) than the English NHS average admitted under general medicine (65 years),
though the National average geriatric admission age is 78 [58]. Both sites are non-specialist
general hospitals and the analysis used medical patients–future studies could examine gener-
alisability to different hospital populations. However, our population probably reflects the
majority of acute admissions in the UK given that the mean age of patients with CA-AKI in
the RISK study being 75 years (unpublished, personal communication with study authors).
The study did not assess whether impact was sustained or whether the intervention could be
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successfully introduced at the control site–the recommended fourth phase of impact analysis
and implementation for example through a time-series design [20]. Calculation of the APS
CPR past history relied on previous coded events attending hospital and could therefore have
been incomplete. The predictive accuracy of the CPR could be improved by planned linkage
with primary care as well as provide information of GP prescribed drugs, known to be associ-
ated with an increased risk of AKI.
Future directions
The concept of a continuously learning healthcare system was articulated by the Institute of
Medicine in the US as a way of showing how evidence informs practice and vice versa in an
iterative process of innovation and collaboration between research, information technology
and clinical practice (summarized Fig 5) [59–61]. This study provides new insights in this
emerging field, and future studies could build on knowledge for example by utilising more
comprehensive records and dynamic data on physiological and blood parameters in the acute
setting. This could enable the electronic record to display risk stratification at multiple time
points from primary care to hospital admission with subsequent updating during an in-patient
Fig 5. The learning health system–AKI as a case study. AI–artificial intelligence.
https://doi.org/10.1371/journal.pone.0200584.g005
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stay. Trends could provide powerful data overcoming limitations of current prediction models
derived at a single time point. This study suggested a benefit from combining a CPR with an e-
alert for HA-AKI. However, NHS England has required AKI alerting for patients presenting to
hospital and this study does not provide evidence to support this to be sufficient to improve
outcomes.
Conclusions
In an impact analysis performed on general medical admissions, introduction of an AKI CPR
was associated with a reduction in HA-AKI. In the context of a multi-faceted intervention,
including an electronically generated care bundle for patients at risk of AKI using a CPR and
e-alert for patients with HA-AKI, a significant reduction in mortality was demonstrated. An e-
alert had no affect on outcomes for patients admitted with established AKI from the commu-
nity. Further studies in the field are warranted to confirm or refute these findings and assess
for generalisability to other hospital populations, healthcare systems, and for sustainability.
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